Both in Management Consulting
Astrana Health vs GENPACT LIMITED
Over the past year ASTH returned +19.8% and G returned +6.1%; their daily moves had a correlation of -0.08.
ASTH +19.8% G +6.1%Growth of $1, one year, split-adjusted
| Metric | ASTH | G |
|---|---|---|
| Price | $39.67 | $40.78 |
| Market cap | $1.97B | $6.82B |
| Today | +8.00% | +1.39% |
| 1 month | +7.2% | +21.9% |
| 6 months | +12.5% | +20.7% |
| Year to date | +59.9% | −12.8% |
| 1 year | +20.2% | +7.0% |
| Revenue growth (YoY) | +48.5% | +7.1% |
| Gross margin | 10.7% | 36.5% |
| Net margin | 2.0% | 10.8% |
| P/E (TTM) | 48.5× | 11.7× |
| Price / sales | 0.5× | 1.3× |
| Net cash | -$535.7M | -$662.9M |
| Dividend yield | — | 1.84% |
| Volatility (60d) | 46.1% | 35.9% |
| Short % of float | 6.8% | 6.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).